Cas 25654-58-4,(S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide

25654-58-4

Post Buying Request

Basic information

Product Name: (S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide
Synonyms: (S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide
CAS NO:25654-58-4
Molecular Formula:
Molecular Weight: 385.634
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide(CAS DataBase Reference)
NIST Chemistry Reference: (S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide(25654-58-4)
EPA Substance Registry System: (S)-(-)-N-(α-methylbenzyl)-9-(Z)-octadecenamide(25654-58-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 25654-58-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

25654-58-4 Suppliers

Recommended suppliers

25654-58-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 25654-58-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,5 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 25654-58:
(7*2)+(6*5)+(5*6)+(4*5)+(3*4)+(2*5)+(1*8)=124
124 % 10 = 4
So 25654-58-4 is a valid CAS Registry Number.

25654-58-4Upstream product

25654-58-4Downstream Products

25654-58-4Relevant academic research and scientific papers

Antiproliferative activity of synthetic fatty acid amides from renewable resources

Dos Santos, Daiane S.,Piovesan, Luciana A.,D'Oca, Caroline R. Montes,Hack, Carolina R. Lopes,Treptow, Tamara G.M.,Rodrigues, Marieli O.,Vendramini-Costa, Débora B.,Ruiz, Ana Lucia T.G.,De Carvalho, Jo?o Ernesto,D'Oca, Marcelo G. Montes

, p. 340 - 347 (2015)

In the work, the in vitro antiproliferative activity of a series of synthetic fatty acid amides were investigated in seven cancer cell lines. The study revealed that most of the compounds showed antiproliferative activity against tested tumor cell lines, mainly on human glioma cells (U251) and human ovarian cancer cells with a multiple drug-resistant phenotype (NCI-ADR/RES). In addition, the fatty methyl benzylamide derived from ricinoleic acid (with the fatty acid obtained from castor oil, a renewable resource) showed a high selectivity with potent growth inhibition and cell death for the glioma cell line - the most aggressive CNS cancer.

Synthesis and antituberculosis activity of new fatty acid amides

D'Oca, Caroline Da Ros Montes,Coelho, Tatiane,Marinho, Tamara Germani,Hack, Carolina Rosa Lopes,Da Costa Duarte, Rodrigo,Da Silva, Pedro Almeida,D'Oca, Marcelo Gonalves Montes

scheme or table, p. 5255 - 5257 (2010/10/03)

This work reports the synthesis of new fatty acid amides from C16:0, 18:0, 18:1, 18:1 (OH), and 18:2 fatty acids families with cyclic and acyclic amines and demonstrate for the first time the activity of these compounds as antituberculosis agents against Mycobacterium tuberculosis H37Rv, M. tuberculosis rifampicin resistance (ATCC 35338), and M. tuberculosis isoniazid resistance (ATCC 35822). The fatty acid amides derivate from ricinoleic acid were the most potent one among a series of tested compounds, with a MIC 6.25 μg/mL for resistance strains.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 25654-58-4